Kaho Kondo

Early initiation of low-dose gilteritinib maintenance improves posttransplant outcomes in patients with R/R FLT3mut AML

D. Ennishi, Toshiki Terao, Y. Maeda, 2022, Blood advances.

Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community Setting

Y. Kondoh, T. Matsuda, R. Takei, 2023, Viruses.

Gilteritinib Maintenance Therapy Post-Allogenic Stem-Cell Transplantation Improves the Prognosis of Patients with FLT3-Mutated AML

D. Ennishi, Toshiki Terao, Y. Maeda, 2022, Blood.

Negative prognostic impact of high-dose or long-term corticosteroid use in patients with relapsed or refractory B-cell lymphoma who received tisagenlecleucel.

D. Ennishi, Toshiki Terao, K. Seike, 2023, Transplantation and cellular therapy.